SE437514B - N-/3-dimetylamino-2-(4-pyridinyl)-2-propenyliden/-n-metylmetaniminiumsalt, sett att framstella detta och kardioton komposition for okning av hjertkontraktiliteten - Google Patents

N-/3-dimetylamino-2-(4-pyridinyl)-2-propenyliden/-n-metylmetaniminiumsalt, sett att framstella detta och kardioton komposition for okning av hjertkontraktiliteten

Info

Publication number
SE437514B
SE437514B SE8101205A SE8101205A SE437514B SE 437514 B SE437514 B SE 437514B SE 8101205 A SE8101205 A SE 8101205A SE 8101205 A SE8101205 A SE 8101205A SE 437514 B SE437514 B SE 437514B
Authority
SE
Sweden
Prior art keywords
pyridinyl
salt
dimethylamino
propenylidene
acid addition
Prior art date
Application number
SE8101205A
Other languages
English (en)
Swedish (sv)
Other versions
SE8101205L (sv
Inventor
K O Gelotte
Jr C J Opalka
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of SE8101205L publication Critical patent/SE8101205L/xx
Publication of SE437514B publication Critical patent/SE437514B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8101205A 1980-02-26 1981-02-24 N-/3-dimetylamino-2-(4-pyridinyl)-2-propenyliden/-n-metylmetaniminiumsalt, sett att framstella detta och kardioton komposition for okning av hjertkontraktiliteten SE437514B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/124,808 US4264609A (en) 1980-02-26 1980-02-26 N-[3-Dimethylamino-2-(4-pyridinyl)-2-propenylidene]-N-methylmethaniminium chloride hydrochloride, its use in preparing 5-(cyano or carbamyl)-[3,4'-bipyridin]-6(1H)-one and its use as a cardiotonic

Publications (2)

Publication Number Publication Date
SE8101205L SE8101205L (sv) 1981-08-27
SE437514B true SE437514B (sv) 1985-03-04

Family

ID=22416880

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8101205A SE437514B (sv) 1980-02-26 1981-02-24 N-/3-dimetylamino-2-(4-pyridinyl)-2-propenyliden/-n-metylmetaniminiumsalt, sett att framstella detta och kardioton komposition for okning av hjertkontraktiliteten
SE8402727A SE452764B (sv) 1980-02-26 1984-05-21 Forfarande for framstellning av 5-(cyano eller karbamyl)-(3,4-bipyridin)-6(1h)-on

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8402727A SE452764B (sv) 1980-02-26 1984-05-21 Forfarande for framstellning av 5-(cyano eller karbamyl)-(3,4-bipyridin)-6(1h)-on

Country Status (28)

Country Link
US (1) US4264609A (de)
JP (1) JPS56128758A (de)
KR (2) KR840002067B1 (de)
AR (1) AR230630A1 (de)
AT (2) AT380237B (de)
AU (1) AU541644B2 (de)
BE (1) BE887663A (de)
CA (1) CA1128523A (de)
CH (1) CH647509A5 (de)
DE (1) DE3107306A1 (de)
DK (1) DK171253B1 (de)
ES (1) ES499776A1 (de)
FI (1) FI76787C (de)
FR (1) FR2476646A1 (de)
GB (1) GB2070600B (de)
HK (1) HK71789A (de)
IE (1) IE51696B1 (de)
IL (1) IL62161A (de)
IT (1) IT1210992B (de)
LU (1) LU83169A1 (de)
MX (1) MX6908E (de)
NL (1) NL192109C (de)
NO (1) NO156689C (de)
NZ (1) NZ196282A (de)
PH (2) PH19904A (de)
PT (1) PT72573B (de)
SE (2) SE437514B (de)
ZA (1) ZA811124B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0200024B1 (de) 1985-04-30 1992-07-01 ARZNEIMITTELWERK DRESDEN GmbH 3-Cyan-pyridine, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4004012A (en) * 1975-10-14 1977-01-18 Sterling Drug Inc. 3-Cyano-5-(pyridinyl)-2(1H)-pyridinones
US4072746A (en) * 1975-10-14 1978-02-07 Sterling Drug Inc. 3-Amino-5-(pyridinyl)-2(1H)-pyridinones

Also Published As

Publication number Publication date
AU6748781A (en) 1981-09-03
NZ196282A (en) 1983-12-16
IT8119952A0 (it) 1981-02-24
DK171253B1 (da) 1996-08-12
PH19904A (en) 1986-08-13
KR830005143A (ko) 1983-08-03
HK71789A (en) 1989-09-14
IE51696B1 (en) 1987-02-18
SE8402727D0 (sv) 1984-05-21
FI76787C (fi) 1988-12-12
IT1210992B (it) 1989-09-29
US4264609A (en) 1981-04-28
CH647509A5 (fr) 1985-01-31
CA1128523A (en) 1982-07-27
LU83169A1 (fr) 1981-09-11
PT72573B (en) 1982-02-12
DE3107306C2 (de) 1990-11-29
NO810639L (no) 1981-08-27
NO156689C (no) 1987-11-04
AR230630A1 (es) 1984-05-31
FI810582L (fi) 1981-08-27
NO156689B (no) 1987-07-27
SE452764B (sv) 1987-12-14
DK83981A (da) 1981-08-27
DE3107306A1 (de) 1981-12-17
BE887663A (fr) 1981-08-25
AT380236B (de) 1986-04-25
MX6908E (es) 1986-11-07
FR2476646B1 (de) 1984-08-17
NL192109B (nl) 1996-10-01
FR2476646A1 (fr) 1981-08-28
ES499776A1 (es) 1984-06-16
IE810397L (en) 1981-08-26
IL62161A0 (en) 1981-03-31
AT380237B (de) 1986-04-25
PH17145A (en) 1984-06-04
ATA305683A (de) 1985-09-15
GB2070600B (en) 1984-07-11
PT72573A (pt) 1981-03-01
ATA88581A (de) 1985-09-15
NL8100922A (nl) 1981-09-16
SE8101205L (sv) 1981-08-27
ZA811124B (en) 1982-03-31
KR840002066B1 (ko) 1984-11-09
SE8402727L (sv) 1984-05-21
IL62161A (en) 1984-06-29
KR840002067B1 (ko) 1984-11-09
JPH0141626B2 (de) 1989-09-06
AU541644B2 (en) 1985-01-17
GB2070600A (en) 1981-09-09
NL192109C (nl) 1997-02-04
JPS56128758A (en) 1981-10-08
FI76787B (fi) 1988-08-31

Similar Documents

Publication Publication Date Title
IE43956B1 (en) Pyridinyl-2n1h)-pyridinones and preparation
NL8201999A (nl) Gesubstitueerde 1,2-diaminocyclobuteen-3,4-dionen, werkwijze voor het bereiden daarvan; geneesmiddelen; werkwijze voor het behandelen van door bemiddeling van histamine h2-receptoren tot stand gekomen toestanden.
EP0350448A1 (de) Biarylverbindungen
CN100355731C (zh) 吡啶衍生物及其用途
US4298609A (en) 4,5-Dihydro-6-(4-pyridinyl)-3-pyridazinol and salts, their preparation and use as blood pressure lowering agents
US4271168A (en) Selected 3-acylamino-5-[4(or 3)-pyridinyl]-2(1H)-pyridinones
SE437514B (sv) N-/3-dimetylamino-2-(4-pyridinyl)-2-propenyliden/-n-metylmetaniminiumsalt, sett att framstella detta och kardioton komposition for okning av hjertkontraktiliteten
NO851113L (no) ((pyridinyl)-2-pyrimidinyl)ureaforbindelser egnet som kardiotoniske midler og fremgangsmaate for deres fremstilling
US4225601A (en) 3-Hydroxy or hydroxymethyl-5-(4-pyridinyl)2(1H)-pyridinones, useful as cardiotonic agents and their preparation
CA1161440A (en) 4-[4(or 3)-acylaminophenyl]pyridines, their preparation and cardiotonic use
US4297362A (en) 4-(3,4-Diaminophenyl)pyridine or salts, and use thereof as cardiotonic
US4376775A (en) N-[4-(4-Pyridinyl)phenyl]ureas and their cardiotonic use
US4362734A (en) 2-(Substituted-amino)-5-(pyridinyl-nicotinonitriles, and their cardiotonic use
US4463008A (en) 2-Alkoxy-5-(pyridinyl)pyridines and cardiotonic use thereof
US4363911A (en) 1,2-Dihydro-6-[2-(dimethylamino)ethenyl]-2-oxo-5-(pyridinyl) nicotinonitriles
US4362735A (en) 3-[(3-Oxo-1-butenyl)amino]-5-(pyridinyl)-2(1H)-pyridinones and their cardiotonic use
US4377585A (en) Use of 4-[4(or 3)-aminophenyl]pyridines as cardiotonic agents
US4305943A (en) 4-Amino-6-(pyridinyl)-3(2H)-pyridazinones and their use as cardiotonics
US4473571A (en) 8-Substituted-2-(4-pyridinyl)-9H-purin-6-amines and their cardiotonic use
EP0074229A1 (de) Triazole mit Magensäuresekretionhemmwirkung
US4361569A (en) 3-(Hydroxy or hydroxymethyl)-6-methyl-5-(4-pyridinyl)-2(1H)-pyridinone and cardiotonic use thereof
US4354026A (en) 3-Chloro-6-(pyridinyl)-pyridazines
US4503228A (en) 2-(Pyridinyl)-4,5,6-pyrimidinetriamines
US4366319A (en) Process for preparing 5-(pyridinyl)benzoxazol-2(3H)-ones
US4335131A (en) Amrinone-N-glucuronide, salts and cardiotonic use thereof

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8101205-6

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8101205-6

Format of ref document f/p: F